DB8 Speech & Debate Academy
Pricing Sign in
Home
Bills Library

Practice bills

Every bill is sorted by grade band and skill level — pick the row that matches you. Built in, no outside sites required.

← All bills
S. 1417·Middle School Experienced

A Bill to Reschedule Fentanyl Analogues Permanently

Sen. Kowalski (R-OH)

Permanently places fentanyl-related substances in Schedule I of the Controlled Substances Act.

Sec. 1 — Mandate

All fentanyl-related substances shall be permanently classified in Schedule I of the Controlled Substances Act.

Sec. 2 — Research Carve-Out

DEA shall maintain a streamlined research authorization process.

Sec. 3 — Funding

$190 million for DEA enforcement and HHS treatment programs.

Sec. 4 — Enforcement

DEA scheduling authority.

Tournament Prep

Mechanical parts, sourced & timed

Use this as your pre-round checklist. Memorize the source citation. Time yourself to the delivery target.

Bill / Number
S. 1417 — A Bill to Reschedule Fentanyl Analogues Permanently
Funding source
$190M for DEA enforcement + HHS treatment.
Timeline
Effective on enactment.
Realistic — converts temporary HALT Fentanyl scheduling to permanent.
Enforcing agency
Drug Enforcement Administration.
Yes — DEA has CSA scheduling authority.
Penalty for non-compliance
CSA criminal penalties — up to 20 years for Schedule I trafficking.
Source citation
CDC NCHS (2024), 'Provisional Drug Overdose Death Counts' — cdc.gov.
Delivery time (read aloud)
1:00 (60s)
Strongest counter-argument

Class-wide scheduling sweeps research chemicals into Schedule I, freezing medical research.

Your pre-emptive answer

Sec. 2 directly creates a streamlined research authorization — addressing the precise critique NIDA raised. CDC (2024) recorded 74,225 fentanyl deaths in 2023; the research carve-out is the structural fix.